InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Sultana Nusrath, Director. Director active across 2 companies, notably SURMODICS INC. Cumulatively, 2 reports have been published. History available since 30 November 2021. The latest transaction was disclosed on 12 February 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Sultana Nusrath is Vice President of Clinical Affairs at Surmodics Inc. She oversees clinical initiatives and contributes to the company's product development strategy.